Equities

MANI Inc

MANI Inc

Actions
Health CareMedical Equipment and Services
  • Price (JPY)1,742.00
  • Today's Change-12.50 / -0.71%
  • Shares traded124.00k
  • 1 Year change-18.50%
  • Beta0.6318
Data delayed at least 20 minutes, as of Nov 22 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Mani Inc is a Japan-based company mainly engaged in the manufacture and sale of medical equipment. The Company operates through three business segments. The Surgical-related Product segment is engaged in the provision of surgical suture needles and threads, as well as ophthalmic knives, born saws, blood vessel knives and other surgical equipment. The Eyeless Needle-related Product segment is engaged in the provision of eyeless surgical suture needles. The Dental-related Product segment is engaged in the manufacture and sale of dental root canal treatment equipment, such as reamers, files, broaches and cleansers; grinding and abrasive agents, such as carborundum points and silicone points; rotating dental treatment equipment, such as diamond burs, carbide burs, stainless burs and others, as well as dental materials, dental stereomicroscopes, among others.

  • Revenue in JPY (TTM)28.51bn
  • Net income in JPY6.29bn
  • Incorporated1959
  • Employees3.69k
  • Location
    MANI Inc8-3, Kiyohara Industrial ParkUTSUNOMIYA-SHI 321-3231JapanJPN
  • Phone+81 286671811
  • Fax+81 286671700
  • Websitehttps://www.mani.co.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Japan Lifeline Co., Ltd.54.24bn7.92bn96.52bn1.22k11.791.6310.081.78108.04108.04738.09779.230.77591.414.0744,602,800.0011.338.6314.0210.8860.3257.2814.6012.281.62--0.088548.80-0.70732.459.06-0.54465.407.69
HOGY MEDICAL CO., LTD.39.18bn2.94bn104.00bn1.41k37.041.3111.452.65124.61124.611,651.563,515.340.38962.693.1127,828,840.002.924.243.214.6731.8639.767.5011.583.80--0.162145.680.30531.30-35.03-14.247.944.56
Menicon Co Ltd118.64bn4.84bn119.18bn4.22k25.651.379.201.0060.6260.621,495.581,132.000.66152.858.6828,106,370.002.704.533.365.6753.4152.974.085.721.28109.350.458327.125.447.51-38.484.8832.6112.30
PHC Holdings Corp360.94bn-6.34bn123.31bn9.25k--0.96335.500.3416-50.71-50.712,859.741,013.240.65873.485.6739,042,080.00-1.17-0.0766-1.55-0.116445.4747.71-1.78-0.12680.82380.70740.6779---0.710913.66-300.16--16.68--
Paramount Bed Holdings Co Ltd104.97bn7.60bn156.80bn4.13k19.311.078.631.49131.51131.511,817.752,368.090.59474.544.6625,441,110.004.305.594.926.5947.8546.917.249.593.70--0.046936.657.085.7715.279.6416.645.39
Mani Inc28.51bn6.29bn187.74bn3.69k27.493.3027.716.5863.8263.82289.47531.170.50851.6611.99--11.2110.6812.0911.4762.7763.1122.0523.776.54--0.001658.3416.449.245.590.596642.0720.53
NAKANISHI INC.75.10bn8.53bn209.35bn2.05k22.331.6314.832.79100.34100.34882.281,373.410.52841.329.4036,650,630.006.0012.717.0614.0256.7561.4111.3626.602.0828.800.12928.1222.6410.3183.1024.6511.2812.30
Ship Healthcare Holdings Inc644.25bn15.64bn216.25bn7.79k12.821.439.520.3357165.87165.876,828.271,488.271.7519.025.5982,670,220.004.173.638.066.869.9510.522.392.291.28--0.24632.0010.267.2814.314.183.095.15
As One Corp100.05bn7.77bn225.46bn711.0026.213.0923.522.25107.86107.861,388.57915.841.086.213.31140,717,100.008.407.6111.1110.4930.1330.797.778.162.17--0.042251.114.507.44-7.557.345.959.70
Nipro Corp612.94bn1.31bn237.99bn38.12k322.990.87113.600.38834.304.303,531.311,593.390.54021.823.6916,080,410.000.22680.79230.3551.2129.3429.990.41981.450.79391.730.690860.827.636.59142.87-1.7510.97-2.24
Fukuda Denshi Co Ltd138.10bn16.59bn276.31bn3.44k12.931.2310.292.00565.94565.944,709.895,965.540.66463.944.0940,109,210.007.988.079.3410.1751.5747.8312.0111.133.59--0.010429.094.211.588.1914.3111.0015.85
Data as of Nov 22 2024. Currency figures normalised to MANI Inc's reporting currency: Japanese Yen JPY

Institutional shareholders

17.73%Per cent of shares held by top holders
HolderShares% Held
Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 30 Jun 20234.48m4.19%
Nomura Asset Management Co., Ltd.as of 07 Nov 20242.49m2.33%
The Vanguard Group, Inc.as of 06 Nov 20242.21m2.06%
Threadneedle Asset Management Ltd.as of 31 Aug 20242.13m1.99%
Rheos Capital Works, Inc. (Investment Management)as of 02 Oct 20231.89m1.76%
Sawakami Asset Management, Inc.as of 30 Aug 20241.45m1.36%
Nikko Asset Management Co., Ltd.as of 30 Jun 20231.19m1.11%
Daiwa Asset Management Co. Ltd.as of 31 Oct 20241.10m1.03%
BlackRock Fund Advisorsas of 07 Nov 20241.04m0.97%
First Sentier Investors (Australia) IM Ltd.as of 30 Jun 20241.00m0.94%
More ▼
Data from 30 Aug 2024 - 14 Nov 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.